Navigation Links
Small Company Contests Big Pharma’s Patent Challenge
Date:5/14/2019

This month, Prollenium Medical Technologies, Inc. filed its answer and counterclaims to a lawsuit by Allergan (C.A. No. 19-126-CFC, filed in the United States District Court for the District of Delaware). Allergan alleges that Prollenium’s hyaluronic acid (HA) dermal filler, Revanesse Versa+, infringes upon several patents it holds, relating to its injectable gel fillers.

The patents in question cover formulations for and methods of manufacturing HA dermal fillers that include lidocaine. Lidocaine is an anesthetic drug that was discovered in 1946 and is widely used for pain treatment in procedures as varied as dental surgery, mole removal, cataract correction, biopsies and nerve blocks. It is included on the World Health Organization’s List of Essential Medicines. For over fifteen years, it’s been used to add comfort to treatments in the medical aesthetic industry.

In its answer and counterclaim, Prollenium Medical Technologies contests the claims and contends that the patents to which they refer – patents on HA compositions cross-linked with butanediol diglycidyl ether (BDDE) and containing lidocaine – are invalid because they claim what was already well known in the art. In its counterclaim Prollenium also alleges that, “Allergan’s patents for cross-linked HA dermal fillers containing Lidocaine, are unenforceable because they are founded on misstatements made to the United States Patent Office, about information that were material to the patentability of the claims.”

“In our opinion, they are using the US patent office as a tool to limit patient and provider choice, and to keep drug costs high. In filing baseless patents, then suing smaller manufacturers to try to enforce them, we believe, they are endeavoring to ensure that they have sole rights to leverage a commonly used, elemental ingredient that eases patient discomfort,” said Khasha Ighanian, President of Prollenium.

“Patents should stimulate innovation and contribute to technological progress. We feel that by patenting the use of a well-understood composition with a common ingredient like lidocaine, they are using the patent system to stifle competition and choice,” said Ario Khoshbin, Prollenium CEO and Founder.

He continued, “We include lidocaine in our product because we believe that patient wellness and comfort can be and should be available to patients and providers as a standard, not a luxury.”

Read the full story at https://www.prweb.com/releases/small_company_contests_big_pharmas_patent_challenge/prweb16305610.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related medicine technology :

1. Pediatric Surgeon Dr. Philip K. Frykman Receives NIH Grant for Research on HAEC, a Potentially Deadly Complication Threatening Infants and Small Children.
2. CarePlus™ Direct is Here, Ensuring Nurse Call is More Accessible to Managers at Day Surgeries and Small Clinics
3. Nutritional Supplement Company Offers Small & Medium Sized Companies Group Discounts
4. National Award Winning Small Town Company Strikes Gold with Charcoal
5. BCMA Targeted Therapies, 2017-2030: Even Though Big Pharmaceutical Companies Dominate the Current Space, Several Start-Ups/Small Companies Have Emerged - Research and Markets
6. Regen BioPharma, Inc. Sees Success in Its Pre-Clinical Small Molecule Optimization Program for NR2F6
7. Asia-Pacific Non-Small Cell Lung Cancer Therapeutics Markets to 2023: Launch of Premium Targeted Therapies and Increasing Prevalence to Drive the Market - Research and Markets
8. Biocept and Catalyst Pharmaceuticals Collaborate to Provide Liquid Biopsy Testing for Small Cell Lung Cancer to Patients with Lambert Eaton Myasthenic Syndrome (LEMS)
9. Heptares Therapeutics Enters Agreement With Daiichi Sankyo to Discover and Develop Novel, Small-molecules for the Treatment of Pain
10. Global Non-Small Cell Lung Cancer Partnering 2010 to 2017
11. BeyondSprings Promising Clinical Data for Lead Asset on Non-Small Cell Lung Cancer Treatment Selected for Presentation at 2017 ASCO-SITC Clinical Immuno-Oncology Symposium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2019)... ... 17, 2019 , ... Dr. Arta Farahmand welcomes patients with ... alternative to conventional orthodontics, the Wilckodontics orthodontic system often cuts treatment time by ... uses brackets and wires that apply constant pressure on the teeth, thus causing ...
(Date:9/17/2019)... ... September 17, 2019 , ... Gustavo Grodnitzky, PhD will join the faculty ... Science as holistic mind/body medicine for physicians and other health care professionals. Entitled ... 2019 at the Cranwell Resort and Spa in Lenox, Massachusetts, is accredited by the ...
(Date:9/14/2019)... ... , ... Corey Stern , a partner at Levy Konigsberg, LLP, now ... over at least 3 decades while employed by Rockefeller University Hospital (“RUH”). Stern has ... Southern District of New York, No. 1:19-cv-01403), the first case filed against the University. ...
Breaking Medicine Technology:
(Date:9/17/2019)... ... September 17, 2019 , ... The ... announce the release of the third edition of The Gift of Participation. Written ... patients, caregivers and families to navigate the clinical research process. The new edition ...
(Date:9/14/2019)... ... September 14, 2019 , ... GreenTheVoteOk , one of the most reliable ... to bring the most relevant and important developments in the fast-changing world of legalized ... number of people across the world suffering from different difficult-to-treat ailments, people need to ...
(Date:9/11/2019)... ANGELES (PRWEB) , ... September 11, 2019 , ... A ... patients who had undergone weight loss surgery were significantly less likely to suffer heart ... who did not undergo bariatric surgery. Los Angeles-based weight loss surgery specialists Dr. Feiz ...
(Date:9/11/2019)... ... September 11, 2019 , ... RMA of Connecticut ... grow their family, will host a free informational event that will demystify fertility age-related ... meal voucher for the first fifty registrants. The event, “What’s Your Real Fertility Age,” ...
(Date:9/11/2019)... Calif. (PRWEB) , ... September 11, 2019 , ... Executives ... and magnitude of change in the healthcare industry over the past several years has ... a lot worse. The future of healthcare in America will depend largely on how ...
Breaking Medicine News(10 mins):